Max Healthcare Institute Limited

NSEI:MAXHEALTH Stock Report

Market Cap: ₹1.1t

Max Healthcare Institute Valuation

Is MAXHEALTH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MAXHEALTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

₹557.81
Fair Value
96.7% overvalued intrinsic discount
24
Number of Analysts

Below Fair Value: MAXHEALTH (₹1097.4) is trading above our estimate of fair value (₹557.81)

Significantly Below Fair Value: MAXHEALTH is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MAXHEALTH?

Key metric: As MAXHEALTH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MAXHEALTH. This is calculated by dividing MAXHEALTH's market cap by their current earnings.
What is MAXHEALTH's PE Ratio?
PE Ratio78.7x
Earnings₹13.57b
Market Cap₹1.07t

Price to Earnings Ratio vs Peers

How does MAXHEALTH's PE Ratio compare to its peers?

The above table shows the PE ratio for MAXHEALTH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average57.4x
APOLLOHOSP Apollo Hospitals Enterprise
61.8x25.29%₹1.0t
FORTIS Fortis Healthcare
66.2x24.81%₹670.8b
NH Narayana Hrudayalaya
46.1x21.30%₹389.3b
MEDANTA Global Health
55.7x19.14%₹312.7b
MAXHEALTH Max Healthcare Institute
78.7x26.69%₹1.1t

Price-To-Earnings vs Peers: MAXHEALTH is expensive based on its Price-To-Earnings Ratio (78.7x) compared to the peer average (57.4x).

Price to Earnings Ratio vs Industry

How does MAXHEALTH's PE Ratio compare vs other companies in the IN Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
MAXHEALTH 78.7xIndustry Avg. 41.5xNo. of Companies9PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MAXHEALTH is expensive based on its Price-To-Earnings Ratio (78.7x) compared to the Indian Healthcare industry average (41.5x).

Price to Earnings Ratio vs Fair Ratio

What is MAXHEALTH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MAXHEALTH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio78.7x
Fair PE Ratio69.3x

Price-To-Earnings vs Fair Ratio: MAXHEALTH is expensive based on its Price-To-Earnings Ratio (78.7x) compared to the estimated Fair Price-To-Earnings Ratio (69.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MAXHEALTH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,097.40
₹1,269.00
+15.64%
14.00%₹1,550.00₹615.00n/a24
Nov ’26₹1,147.80
₹1,255.38
+9.37%
14.44%₹1,550.00₹615.00n/a24
Oct ’26₹1,113.20
₹1,249.13
+12.21%
14.17%₹1,500.00₹615.00n/a24
Sep ’26₹1,181.20
₹1,252.35
+6.02%
14.30%₹1,500.00₹615.00n/a23
Aug ’26₹1,246.00
₹1,201.13
-3.60%
13.88%₹1,400.00₹615.00n/a23
Jul ’26₹1,279.70
₹1,191.57
-6.89%
14.06%₹1,400.00₹615.00n/a23
Jun ’26₹1,125.20
₹1,191.57
+5.90%
14.06%₹1,400.00₹615.00n/a23
May ’26₹1,098.20
₹1,154.83
+5.16%
14.02%₹1,390.00₹615.00n/a23
Apr ’26₹1,083.60
₹1,151.14
+6.23%
14.27%₹1,390.00₹615.00n/a22
Mar ’26₹978.10
₹1,151.14
+17.69%
14.27%₹1,390.00₹615.00n/a22
Feb ’26₹1,108.25
₹1,144.76
+3.29%
14.51%₹1,390.00₹615.00n/a21
Jan ’26₹1,139.60
₹1,091.75
-4.20%
15.10%₹1,380.00₹615.00n/a20
Dec ’25₹979.75
₹1,084.75
+10.72%
14.30%₹1,250.00₹615.00₹1,125.4020
Nov ’25₹1,007.55
₹940.05
-6.70%
13.59%₹1,238.00₹560.00₹1,147.8019
Oct ’25₹970.20
₹938.32
-3.29%
13.80%₹1,240.00₹560.00₹1,113.2019
Sep ’25₹862.45
₹922.00
+6.90%
12.12%₹1,060.00₹560.00₹1,181.2019
Aug ’25₹924.00
₹872.78
-5.54%
11.77%₹1,060.00₹560.00₹1,246.0018
Jul ’25₹955.80
₹860.33
-9.99%
10.81%₹950.00₹560.00₹1,279.7018
Jun ’25₹751.80
₹855.06
+13.73%
12.97%₹950.00₹465.00₹1,125.2018
May ’25₹840.30
₹844.24
+0.47%
13.86%₹950.00₹465.00₹1,098.2017
Apr ’25₹817.25
₹832.31
+1.84%
14.30%₹940.00₹465.00₹1,083.6016
Mar ’25₹736.75
₹827.13
+12.27%
14.61%₹940.00₹465.00₹978.1015
Feb ’25₹803.10
₹738.31
-8.07%
16.42%₹925.00₹465.00₹1,108.2516
Jan ’25₹688.45
₹657.40
-4.51%
10.76%₹780.00₹465.00₹1,139.6015
Dec ’24₹652.35
₹644.73
-1.17%
9.65%₹730.00₹465.00₹979.7515
₹1.27k
Fair Value
13.5% undervalued intrinsic discount
24
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/06 12:15
End of Day Share Price 2025/12/05 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Max Healthcare Institute Limited is covered by 43 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pranav ChawlaAmbit Capital
Nitin BhasinAmbit Capital
Ashwin MehtaAmbit Capital